TITLE

In patients with atrial fibrillation, adding clopidogrel to aspirin reduced major vascular events but increased bleeding

AUTHOR(S)
Cairns, John A; Connolly, S. J.
PUB. DATE
September 2009
SOURCE
ACP Journal Club;9/22/2009, Vol. 151 Issue 3, p6
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents the findings of a study to assess whether adding clopidogrel to aspirin reduces risk for vascular events in patients with atrial fibrillation (AF) who are unsuitable for vitamin K antagonist therapy. The research method included randomized placebo controlled trials. The study concluded that aspirin with clopidogrel reduced risk for major vascular events but increased risk for major bleeding.
ACCESSION #
44638105

 

Related Articles

  • Clopidogrel + aspirin in atrial fibrillation.  // Neurology Alert;Aug2009 Clinical Briefs in, Vol. 14 Issue 8, p15 

    The article discusses the effect of clopidogrel (CPG) when combined with aspirin (ASA) in the treatment of patients with atrial fibrillation (FIB). It references a study by The ACTIVE Investigators, published in the 2009 issue of "N Engl J Med." Some FIB patients with indications for coumadin...

  • Clopidogrel + aspirin in atrial fibrillation. Kuritzky, Louis // Clinical Cardiology Alert;Aug2009 Clinical Briefs in, Vol. 14 Issue 8, p15 

    The article discusses research on the clinical use of clopidogrel and aspirin in atrial fibrillation. It references the study "The ACTIVE Investigators. Effect of Clopidogrel Added to Aspirin in Patients With Atrial Fibrillation," published in the 2009 issue of the "New England Journal of...

  • The P450 system and CV outcomes with clopidogrel.  // Internal Medicine Alert;12/15/2010, Vol. 32 Issue 23, p183 

    The article reports on the findings of a study concerning the use of CYP2C19 genotyping to determine the efficacy of clopidogrel treatment for persons with atrial fibrillation in the U.S.

  • Efficacy and safety of aspirin, clopidogrel, and warfarin after coronary artery stenting in Korean patients with atrial fibrillation. Suh, Soon; Kang, Woong; Oh, Pyung; Choi, Hanul; Moon, Chan; Lee, Kyounghoon; Han, Seung; Ahn, Taehoon; Choi, In; Shin, Eak // Heart & Vessels;Sep2014, Vol. 29 Issue 5, p578 

    There are limited data on the optimal antithrombotic therapy for patients with atrial fibrillation (AF) who undergoing coronary stenting. We reviewed 203 patients (62.6 % men, mean age 68.3 ± 10.1 years) between 2003 and 2012, and recorded clinical and demographic characteristics of the...

  • ASA or low-molecular-weight heparin in the initial management of acute ischemic stroke complicating atrial fibrillation? Farquhar, Donald // CMAJ: Canadian Medical Association Journal;2/06/2001, Vol. 164 Issue 3, p396 

    Reports on a study to determine if low-molecular-weight heparin (LMWH) is superior to aspirin in preventing early recurrent ischemic stroke in patients with atrial fibrillation. Background; Design; Results; Conclusion that there is no evidence that anticoagulation with LMWH is superior to...

  • Perioperative Bridging Anticoagulation Unhelpful for Invasive Procedures. EBELL, MARK H. // American Family Physician;1/15/2016, Vol. 93 Issue 2, p130 

    The article examines whether bridging anticoagulation during invasive procedures improve outcomes in patients with atrial fibrillation who take warfarin, or Coumadin. Topics discussed include warfarin obtained by participants for three months, absence of anticoagulation in the placebo group for...

  • COMMENTARY: Warfarin reduced major stroke more than aspirin in elderly patients with atrial fibrillation in primary care. Jaffer, Amir K. // ACP Journal Club;Nov/Dec2007, Vol. 147 Issue 3, p59 

    The author reflects on the findings of a study, that focused on the effectiveness of warfarin, over aspirin in elderly primary care patients with atrial fibrillation (AF). He states that even though stroke risk in AF, warfarin is underutilized to cure elderly patients suffering from AF. He...

  • How Should Results from Completed Studies Influence Ongoing Clinical Trials? Laupacis, Andreas; Connolly, Stuart J.; Gent, Michael; Roberts, Robin S.; Cairns, John; Joyner, Campbell // Annals of Internal Medicine;11/15/91, Vol. 115 Issue 10, p818 

    Presents a study which evaluated the efficacy of warfarin or aspirin or both in decreasing the risk of embolic events in patients with nonrheumatic atrial fibrillation. Description of atrial fibrillation and the clinical studies; Influence of completed studies on ongoing clinical trials.

  • Aspirin may increase bleeding risk in atrial fibrillation patients on oral anticoagulants.  // Hem/Onc Today;9/25/2013, Vol. 14 Issue 18, p10 

    The article focuses on researcher B.A. Steinberg's analysis of data from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry which indicated that concomitant aspirin therapy may increase bleeding risk in patients with atrial fibrillation (AF).

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics